JPS51110015A - - Google Patents

Info

Publication number
JPS51110015A
JPS51110015A JP51022291A JP2229176A JPS51110015A JP S51110015 A JPS51110015 A JP S51110015A JP 51022291 A JP51022291 A JP 51022291A JP 2229176 A JP2229176 A JP 2229176A JP S51110015 A JPS51110015 A JP S51110015A
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP51022291A
Other languages
Japanese (ja)
Inventor
Shutsuto Heruman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Bayer AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer AG filed Critical Bayer AG
Publication of JPS51110015A publication Critical patent/JPS51110015A/ja
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81Protease inhibitors
    • C07K14/8107Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811Serine protease (E.C. 3.4.21) inhibitors
    • C07K14/8114Kunitz type inhibitors
    • C07K14/8117Bovine/basic pancreatic trypsin inhibitor (BPTI, aprotinin)
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/8215Microorganisms
    • Y10S435/822Microorganisms using bacteria or actinomycetales
    • Y10S435/832Bacillus
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/8215Microorganisms
    • Y10S435/822Microorganisms using bacteria or actinomycetales
    • Y10S435/842Clostridium
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/8215Microorganisms
    • Y10S435/911Microorganisms using fungi
    • Y10S435/913Aspergillus

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
JP51022291A 1975-03-05 1976-03-03 Pending JPS51110015A (US20050192411A1-20050901-C00001.png)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2509482A DE2509482C2 (de) 1975-03-05 1975-03-05 Verfahren zur Herstellung des Kallikrein-Trypsin-Inhibitors aus Rinderlunge

Publications (1)

Publication Number Publication Date
JPS51110015A true JPS51110015A (US20050192411A1-20050901-C00001.png) 1976-09-29

Family

ID=5940477

Family Applications (1)

Application Number Title Priority Date Filing Date
JP51022291A Pending JPS51110015A (US20050192411A1-20050901-C00001.png) 1975-03-05 1976-03-03

Country Status (5)

Country Link
US (1) US4035234A (US20050192411A1-20050901-C00001.png)
JP (1) JPS51110015A (US20050192411A1-20050901-C00001.png)
AR (1) AR208026A1 (US20050192411A1-20050901-C00001.png)
DE (1) DE2509482C2 (US20050192411A1-20050901-C00001.png)
FR (1) FR2303025A1 (US20050192411A1-20050901-C00001.png)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2615436C2 (de) * 1976-04-09 1985-11-21 Bayer Ag, 5090 Leverkusen Verfahren zur Entfernung von inaktiven Begleitproteinen und Begleitpolypeptiden aus Lösungen des Kallikrein- Trypsin-Inhibitors
CN102812118B (zh) 2010-04-08 2016-01-20 恰根有限公司 分离和纯化核酸的方法
EP2556158B1 (en) 2010-04-08 2019-12-18 Qiagen GmbH Chromatographic device and method for isolating and purifying nucleic acids
WO2011124708A1 (en) * 2010-04-08 2011-10-13 Qiagen Gmbh Method for precipitating anionic surfactant ions in the presence of nucleic acids
EP2395082A1 (en) 2010-06-14 2011-12-14 QIAGEN GmbH Extraction of nucleic acids from wax-embedded samples
EP3390671B1 (en) * 2016-02-11 2019-10-09 HTG Molecular Diagnostics, Inc. Method of direct target sequencing using nuclease protection
FR3147326A1 (fr) 2023-03-29 2024-10-04 Psa Automobiles Sa Strategie de coordination de la regulation de charge en air d’un moteur a combustion interne essence turbocompresse

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1517753B2 (de) * 1966-05-26 1973-11-29 Bayer Ag, 5090 Leverkusen Verfahren zur Anreicherung von Enzym Inhibitoren
CH617963A5 (US20050192411A1-20050901-C00001.png) * 1973-10-05 1980-06-30 Derivati Organici Lab

Also Published As

Publication number Publication date
US4035234A (en) 1977-07-12
DE2509482A1 (de) 1976-09-16
FR2303025A1 (fr) 1976-10-01
DE2509482C2 (de) 1985-11-21
FR2303025B3 (US20050192411A1-20050901-C00001.png) 1978-12-01
AR208026A1 (es) 1976-11-22

Similar Documents

Publication Publication Date Title
CH596345A5 (US20050192411A1-20050901-C00001.png)
FR2303025B3 (US20050192411A1-20050901-C00001.png)
JPS579453B2 (US20050192411A1-20050901-C00001.png)
JPS5329625Y2 (US20050192411A1-20050901-C00001.png)
JPS5540112B2 (US20050192411A1-20050901-C00001.png)
JPS5744193B2 (US20050192411A1-20050901-C00001.png)
JPS5277580U (US20050192411A1-20050901-C00001.png)
CS177382B1 (US20050192411A1-20050901-C00001.png)
CH606895A5 (US20050192411A1-20050901-C00001.png)
AU480071A (US20050192411A1-20050901-C00001.png)
CH590481A5 (US20050192411A1-20050901-C00001.png)
CH589394A5 (US20050192411A1-20050901-C00001.png)
CH587511B5 (US20050192411A1-20050901-C00001.png)
CH587505A5 (US20050192411A1-20050901-C00001.png)
CH1355175A4 (US20050192411A1-20050901-C00001.png)
BG22878A1 (US20050192411A1-20050901-C00001.png)
BG22696A1 (US20050192411A1-20050901-C00001.png)
BG22542A1 (US20050192411A1-20050901-C00001.png)
BG22483A1 (US20050192411A1-20050901-C00001.png)
CH607460A5 (US20050192411A1-20050901-C00001.png)
BG22431A1 (US20050192411A1-20050901-C00001.png)
BG22335A1 (US20050192411A1-20050901-C00001.png)
BG22316A1 (US20050192411A1-20050901-C00001.png)
BG22273A1 (US20050192411A1-20050901-C00001.png)
CH592300A5 (US20050192411A1-20050901-C00001.png)